These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 12520694

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Biomarkers and drug development 2009.
    Ross JS.
    Expert Opin Med Diagn; 2009 Sep; 3(5):471-8. PubMed ID: 23495978
    [Abstract] [Full Text] [Related]

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluating the value of genomic diagnostics: implications for clinical practice and public policy.
    Issa AM.
    Adv Health Econ Health Serv Res; 2008 Dec; 19():191-206. PubMed ID: 19548519
    [Abstract] [Full Text] [Related]

  • 8. Personalized medicine.
    Jain KK.
    Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
    [Abstract] [Full Text] [Related]

  • 9. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P.
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [Abstract] [Full Text] [Related]

  • 10. Toward theragnostics.
    Pene F, Courtine E, Cariou A, Mira JP.
    Crit Care Med; 2009 Jan; 37(1 Suppl):S50-8. PubMed ID: 19104225
    [Abstract] [Full Text] [Related]

  • 11. Molecular diagnostics: an FDA perspective.
    Ardekani AM, Petricoin EF, Hackett JL.
    Expert Rev Mol Diagn; 2003 Mar; 3(2):129-40. PubMed ID: 12647991
    [Abstract] [Full Text] [Related]

  • 12. Implications of pharmacogenomics for drug development.
    Kirk RJ, Hung JL, Horner SR, Perez JT.
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536
    [Abstract] [Full Text] [Related]

  • 13. Translating genomic biomarkers into clinically useful diagnostics.
    Ginsburg GS, Haga SB.
    Expert Rev Mol Diagn; 2006 Mar; 6(2):179-91. PubMed ID: 16512778
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.
    Walk EE.
    Curr Opin Drug Discov Devel; 2010 Mar; 13(2):226-34. PubMed ID: 20205056
    [Abstract] [Full Text] [Related]

  • 17. Challenges of drug discovery for personalized medicine.
    Jain KK.
    Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
    [Abstract] [Full Text] [Related]

  • 18. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A, Martin P.
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.